▶ Full Post Text
BSB News For Week #203, September 7th 2026
Monitor the best BSB stockpickers f[rom the 2026 contest](https://docs.google.com/spreadsheets/d/1wbluSfSxlanF5klcKoOuOmrLpndsaRzWlCujQUVPZTs/), thanks atWork Office Furniture Canada! Who are generously sponsoring the winner with a $1,000 credit plus free nationwide delivery.
# Monday:
# X
# Tuesday:
# Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets — BHC.tse
>Bausch Health (NYSE/TSX: BHC) is expanding its skincare partnership with Belgian microbiome-tech firm YUN into Mexico and additional EMEA markets (Czech Republic, Slovakia, Ukraine, Bulgaria, with Kazakhstan launching October 2026), building on the 2025 Poland launch. No financial terms, deal structure, or contract value were disclosed.
#
# Wednesday:
# X
#
# Thursday:
# Volatus Aerospace Awarded Canadian Defence Contract for Tactical ISR Uncrewed Aircraft Systems for up to 5,000 systems — FLT.tse
>Volatus Aerospace (TSX: FLT; OTCQX: TAKOF) awarded a five-year Government of Canada contract for tactical ISR uncrewed aircraft systems: initial order of 100 units, with options for up to 4,900 more (5,000 total) at Canada's discretion. Government framework caps pricing at C$5,000/unit and C$25M total envelope; Volatus' actual contracted pricing was not disclosed. Options are not committed revenue or backlog. Initial delivery expected Q4 2026.
# XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™ — XRTX.v
>XORTX Therapeutics (NASDAQ: XRTX) began contract manufacturing of GMP oxypurinol drug substance and commercial-scale XORLO™ tablets to supply its planned two-part XRX-OXY-102 clinical trial for gout, using its proprietary synthesis pathway, with validation/stability data intended to support a future FDA NDA filing. No manufacturing costs, contract value, trial timeline, or manufacturing partner name were disclosed.
# TTGI'S Insentra Expands IGEL Ecosystem in ANZ as Pipeline Grows 50% Year-Over-Year; Announces CFO Transition — TTGI.v
>Turnium Technology Group's (TSXV: TTGI) Insentra subsidiary reports its IGEL reseller network grew to 45 certified ANZ partners (from 33 a year ago, +12 in 2026 YTD), with IGEL-related pipeline up \~50% year-over-year. No revenue, contract value, or other dollar figures disclosed. Note: headline references a CFO transition, but no details on that change were included in the release text provided.
# MDA SPACE UNVEILS MDA AURORA™ BLACK, A DEFENCE-FOCUSED SOFTWARE-DEFINED SATELLITE — MDA.tse
>MDA Space (TSX/NYSE: MDA) launched MDA AURORA™ BLACK, a defence-focused variant of its software-defined satellite line adding anti-jamming, GPS-spoofing resistance, and cyber/physical hardening for military SATCOM. No customer contracts, revenue, pricing, or deal terms were disclosed; release cites third-party industry context (2023: 107 defence satellites launched, \~US$40B in contracted government space-defence spending) rather than company-specific figures.
# Critical Infrastructure Technologies Executes Strategic MOU with Leading Polish Defence and Industrial Partners for Nexus — CTTT.cse
>Critical Infrastructure Technologies (CSE: CTTT) signed an MOU with Polish defence firms WZM and H. Cegielski-Poznan to localize manufacturing, integration and support of its Nexus 20 autonomous platform in Poland for Central/Eastern Europe and NATO Eastern Flank markets, building on a February 2026 LOI. The MOU sets a path to three definitive agreements (sales/marketing, manufacturing, maintenance/support). No deal value, revenue, or financial terms were disclosed.
#
# Friday:
# Hypercharge Enters into Letter of Intent to Acquire REVS Charging LLC — HC.v
>Hypercharge Networks (TSXV: HC) signed a non-binding LOI to acquire 100% of Texas-based REVS Charging for \~US$4.75M: US$3M in shares (deemed C$0.23), US$500,000 cash at closing, plus up to US$1.25M in deferred shares over three years on gross-profit milestones (VWAP-priced, C$0.23–C$0.50 range). \~18.1M shares issue at closing, up to 7.6M more on earn-outs. A US$200,000 interim loan (US$150,000 drawn) is repayable with 5% interest if the deal fails. Expected close Q3 2026.